Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2026-02-23 @ 12:12 AM
Study NCT ID:
NCT03308968
Status:
COMPLETED
Last Update Posted:
2021-11-09
First Post:
2017-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Migraine Prophylaxis | View |
Keywords: